Damora Therapeutics grants options for 120,900 shares to five new employees

PUBT · 1d ago
Damora Therapeutics grants options for 120,900 shares to five new employees
  • Damora Therapeutics granted options to purchase 120,900 ordinary shares to five newly hired, non-executive employees on November 1, 2026.
  • The options have a 10-year term and an exercise price of $21.49 per share.
  • Vesting begins at 25% on each employee's first start-date anniversary, with the remainder vesting in equal monthly installments over 36 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611051601PRIMZONEFULLFEED9871682) on November 05, 2026, and is solely responsible for the information contained therein.